Rhinitis, Allergic, Perennial and Seasonal Clinical Trial
Official title:
An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance (PMS) to Monitor the Safety and Effectiveness of Avamys® Administered in Korean Patients According to the Prescribing Information
Non-interventional, open-label, single group, multicentric post-marketing surveillance to
monitor the safety and effectiveness of AVAMYS nasal spray administered in Korean patients
according to the prescribing information.
AVAMYS is a registered trademark of the GSK group of companies.
n/a
Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02424539 -
A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR)
|
Phase 4 | |
| Completed |
NCT01949051 -
A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic Rhinitis
|
Phase 2 | |
| Completed |
NCT01957202 -
A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)
|
Phase 2 | |
| Completed |
NCT01962467 -
A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine
|
Phase 1 | |
| Completed |
NCT01622283 -
Pharmacokinetic Study of Levocetirizine Oral Solution
|
Phase 1 | |
| Completed |
NCT02397915 -
Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays
|
Phase 4 | |
| Completed |
NCT01445262 -
Drug Use Investigation for XYZAL®
|
N/A | |
| Completed |
NCT01916226 -
A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis
|
Phase 4 | |
| Completed |
NCT00109486 -
Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray
|
Phase 3 |